SCHEMBL30767334

SCHEMBL30767334

CC(C)(C)c1nnc(-c2cc3c(cc2F)C(F)(F)C[C@H](N)C(=O)N3Cc2ccc(OC3CCCC3)cc2)o1

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 1/20 0.35
▸ KCNH2 Q12809 9/20 0.33
▸ MCHR1 Q99705 9/20 0.33
▸ APP P05067 1/20 0.31
▸ AXL P30530 1/20 0.30
▸ FLT3 P36888 1/20 0.30
▸ TYRO3 Q06418 1/20 0.30
▸ MERTK Q12866 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30767323 1.00 GRM2 (0.35) GRM2KCNH2MCHR1APPAXL
SCHEMBL30767545 1.00 GRM2 (0.35) GRM2KCNH2MCHR1APPAXL
SCHEMBL30767358 0.90 GRM2 (0.36) GRM2
SCHEMBL31664973 0.89 KCNH2 (0.34) GRM2KCNH2MCHR1APPAXL
SCHEMBL30767646 0.87 KCNH2 (0.33) GRM2KCNH2MCHR1APPAXL
SCHEMBL30767443 0.87 KCNH2 (0.33) GRM2KCNH2MCHR1APPAXL
SCHEMBL30767522 0.87 KCNH2 (0.33) GRM2KCNH2MCHR1APPAXL
SCHEMBL30767347 0.85 GRM2 (0.34) GRM2
SCHEMBL30767395 0.85 GRM2 (0.34) GRM2
SCHEMBL30767435 0.85 GRM2 (0.34) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568960-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-06-18 — — EP claimed
WO-2024033458-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-02-15 — — WO claimed
EP-4568960-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-06-18 — — EP disclosed
WO-2024033458-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-02-15 — — WO disclosed
Send feedback